GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (FRA:Q9T) » Definitions » Earnings Power Value (EPV)

ME Therapeutics Holding (FRA:Q9T) Earnings Power Value (EPV) : €0.04 (As of Aug24)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Earnings Power Value (EPV)?

As of Aug24, ME Therapeutics Holding's earnings power value is €0.04. *

* GuruFocus does not store EPV value into our database if Average Maintenance CAPEX is 0.

Margin of Safety is N/A.

The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future. Assumption: Current profitability is sustainable.


ME Therapeutics Holding Earnings Power Value (EPV) Historical Data

The historical data trend for ME Therapeutics Holding's Earnings Power Value (EPV) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Earnings Power Value (EPV) Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23 Aug24
Earnings Power Value (EPV)
- - -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24 May24 Aug24
Earnings Power Value (EPV) Get a 7-Day Free Trial - - - - -

Competitive Comparison of ME Therapeutics Holding's Earnings Power Value (EPV)

For the Biotechnology subindustry, ME Therapeutics Holding's Earnings Power Value (EPV), along with its competitors' market caps and Earnings Power Value (EPV) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ME Therapeutics Holding's Earnings Power Value (EPV) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's Earnings Power Value (EPV) distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's Earnings Power Value (EPV) falls into.



ME Therapeutics Holding Earnings Power Value (EPV) Calculation

Earnings Power Value also known as just Earnings Power is a valuation technique popularised by Bruce Greenwald, an authority on value investing at Columbia University. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future.

The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. This valuation tool excludes the potential growth that a company may have so that needs to be looked at separately. Since future growth is excluded from the analysis, only the maintenance capital expenditures are subtracted from after-tax EBIT (earnings before interest and taxes) and growth capex is ignored.


ME Therapeutics Holding  (FRA:Q9T) Earnings Power Value (EPV) Explanation

Assumption: Current profitability is sustainable.

Earnings power value (EPV) uses a very basic equation which assumes no growth, although it does rely on an assumption about the cost of capital as well as the fact that current earnings are sustainable. It also involves several adjustments to clean up the underlying Earnings figures.


Be Aware

Though using today's earnings in calculating Earnings Power Value, GuruFocus is normalizing these earnings to the business cycle. This eliminates the effects on profitability of valuing the firm at different points in the business cycle. This means that we are considering the average earnings over 5 years.


ME Therapeutics Holding Earnings Power Value (EPV) Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Earnings Power Value (EPV) provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding Business Description

Comparable Companies
Traded in Other Exchanges
Address
177 Robson St., Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding Headlines

No Headlines